Skip to content
Sharism- Lifestyle
Author:
Cellectis Inc.
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting
April 27, 2026
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
April 13, 2026
Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
March 12, 2026
←
Previous Page
1
2